Celea Therapeutics

Develops investigational therapies for serious respiratory diseases, including idiopathic pulmonary fibrosis

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-11-14

Recent signals

What changed at Celea Therapeutics in the last 6 months, newest first. Each line links to its public source.

Get signals like these for the companies you sell to →

About Celea Therapeutics

Celea Therapeutics develops deupirfenidone, an investigational antifibrotic therapy for idiopathic pulmonary fibrosis (IPF) and other fibrotic lung diseases. Its lead program is in Phase 3 development, and the company describes the treatment as an oral tablet.

The company was founded by PureTech Health. Its open roles are based in Boston and include positions in clinical development, regulatory affairs, IT, communications and legal.

Product: Deupirfenidone, an investigational oral antifibrotic therapy for idiopathic pulmonary fibrosis and other fibrotic lung diseases.

Jobs at Celea Therapeutics

No open positions in Europe right now.

Open roles at Celea Therapeutics in the Americas (2)

United States 2. From Celea Therapeutics's careers page or applicant tracking system; each role links to the employer.

More biotech & pharma companies

  • Cellanome

    Live-cell imaging and single-cell transcriptomics platform for biology research labs and biopharma companies
    United StatesBiotech & pharma
    New on Evolc
  • Cellarity

    AI and multi-omics drug discovery of oral medicines that correct dysfunctional cell states in complex diseases
    United StatesBiotech & pharma
    New on Evolc
  • Cellular Intelligence

    Develops AI and biology approaches to engineer cell fate for biomedical and drug-development applications
    United StatesBiotech & pharma
    New on Evolc
  • Centrillion Technologies

    High-density DNA chips and molecular measurement platforms for life science researchers and diagnostic partners
    Palo Alto, United StatesBiotech & pharma
    New on Evolc
  • Chai Discovery

    AI-based molecular design tools for pharmaceutical and life sciences companies developing medicines
    United StatesBiotech & pharma
    New on Evolc
  • Climb Bio

    Develops monoclonal antibody medicines for people with immune-mediated diseases
    United StatesBiotech & pharma
    New on Evolc

All biotech & pharma companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

Analytics

  • Google Analytics 4High confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Content management

  • SquarespaceHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Frontend frameworks

  • jQueryHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Recruiting

  • GreenhouseMedium confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.